Page 1 in Annual Report 2003

Active Biotech develops innovative drugs that regulate the body's own immune defence. We focus on widespread diseases in need of new and more efficient forms of treatment. We have progressed furthest with our candidate drugs for the treatment of MS and cancer. 03 ANNUAL REPORT 2003

  Page 2 - Maximum benefit with minimum bureaucracy Active Biotech always designs its project  
Archive:
Annual Report 2000
Annual Report 2001
Annual Report 2002
Annual Report 2004
Annual Report 2005
Annual Report 2006
Annual Report 2007
Annual Report 2008
Annual Report 2009
Annual Report 2010
Annual Report 2011
Annual Report 2012
To read this myPaper publication you need to have JavaScript activated in your web browser. You also need to have at least Flash Version 6 installed.